lobbying_activities: 666305

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
666305	ba1eddb5-9e83-444e-8282-1870f25fcf79	Q3	POLICY DIRECTIONS INC.	31747	RECKITT BENCKISER LLC (FORMERLY KNOWN AS RECKITT BENCKISER)	2008	third_quarter	LAW	S. 2274, Dextromethorphan Abuse Reduction Act of 2007, proposed scheduling of unfinished Dextromethophan as a Schedule V product under the Controlled Substances Act and mandates restriction for the sale of retail products which contain Dextromethorphan. S.2237, Crime Control and Prevention Act of 2007, Subtitle B containing the same provisions as in the Dextromethorphan Abuse Reduction Act of 2007.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2008-10-15T11:55:25-04:00